Alterations in gut microbiota composition in children with methylmalonic acidemia, propionic acidemia, and maple syrup urine diseaseOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined gut microbiota composition in children with three rare, monogenic intoxication-type inborn errors of metabolism: methylmalonic acidemia (MMA), propionic acidemia (PA), and maple syrup urine disease (MSUD). All affected children were on medically supervised, protein-restricted diets, which the authors note may itself alter the gut microbiome. Fecal samples were analyzed using 16S rRNA sequencing, and both alpha and beta diversity were assessed. The authors highlight that no prior study had characterized gut microbiota in MMA or MSUD specifically.
Who was studied?
The cohort consisted of eight children with these disorders (five with MMA, one with PA, and two with MSUD), all following a protein-restricted diet under medical supervision. Eleven age-matched healthy children served as controls. This is a small, real-world pediatric clinical sample rather than a public dataset, reflecting the rarity of these inborn errors of metabolism.
What were the most important findings?
Patients with MMA, PA, and MSUD showed significantly altered gut microbiota composition compared to healthy controls. Alpha diversity was reduced in patients, with significantly lower Chao1 and observed OTU indices, indicating decreased microbial richness. Beta diversity analysis showed distinct clustering, meaning the overall community structure differed significantly between patient and control groups. The abstract does not mention Faecalibacterium prausnitzii, butyrate, or specific anti-inflammatory commensal taxa.
What are the greatest implications of this study?
These findings suggest that children managing MMA, PA, or MSUD with strict protein-restricted diets may develop a less rich and structurally distinct gut microbiome relative to healthy peers. Because this is the first data available for MMA and MSUD, it establishes a baseline for future research into how dietary protein restriction and disease biology jointly shape the microbiome in these disorders. Given the very small sample size, these results should be viewed as preliminary and hypothesis-generating rather than conclusive. Larger studies are needed to clarify whether microbiota alterations relate to disease pathophysiology, dietary restriction, or both, and whether they carry clinical consequences.